| Name | MERS-CoV-IN-1 |
|---|
| Description | MERS-CoV-IN-1 exhibits excellent inhibitory activity against coronavirus. MERS-CoV-IN-1 is useful as a pharmaceutical composition for preventing coronavirus-induced diseases (MERS-CoV and SARS) (extracted from patent WO2018174442A1, compound 1)[1]. |
|---|---|
| Related Catalog | |
| Target |
MERS-CoV and SARS[1] |
| References |
[1]. Compound for treating diseases caused by coronavirus infection. Patent WO2018174442A1. |
| Molecular Formula | C19H17NO2 |
|---|---|
| Molecular Weight | 291.34 |